VLA 0.00% $1.75 viralytics limited

ann out: pancreatic cancer research, page-2

  1. 156 Posts.
    Great development, but I really think that VLA management needs to update on what the progress is with the Phase II application. I don't need a definitive answer, but I need my expectations managed about what the issues are and when they expect them to be resolved, or at least when they expect to hear back next from the FDA.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.